The smaller sized particles result in increased oral and cellular uptake and faster transmucosal absorption in the mouth, in addition to enhanced absorption throughout the rest of the gastrointestinal tract
Most patients experience side effects within the first week of starting treatment or following a dose increase, with gastrointestinal symptoms such as nausea being particularly common
The commentary is not meant to diagnose, treat or replace conventional treatment, and has not been approved or reviewed by the FDA, Health Canada, BMS, European Union Health Commission, South and Central American regulation agencies etc.
However, you should never take it with other GLP-1 agonists, such as Ozempic, Victoza (liraglutide), or Mounjaro (tirzepatide), as this can lead to serious side effects like low blood sugar, nausea, vomiting, and diarrhea
What Is the Difference Between 503a and 503b Pharmacies